Skip to main content

ICUI

Icu Medical Inc/De
$154.97 +6.51 (+4.39%) At close · Jul 2
Market Cap
$3.87B
Shares
24,993,585

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-05-07 ICU Medical Announces First Quarter 2026 Results

SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2026. First Quarter 2026 Results The following

2026-04-23 ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.

2026-02-23 ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Raymond James 47th Annual Institutional Investors

2026-02-19 ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.

2026-02-05 ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call.

2025-12-31 ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

SAN CLEMENTE, Calif. , Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San

2025-11-20 ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference

SAN CLEMENTE, Calif. , Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare

2025-11-06 ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

SAN CLEMENTE, Calif. , Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025 .

2025-10-23 ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call

SAN CLEMENTE, Calif. , Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.

2025-08-21 ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif. , Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: Wells Fargo 2025 Healthcare Conference on

Past events

Source: https://ir.icumed.com/

Key facts CIK 883984 CUSIP 44930G107 13F (30d) 4 filings 3 filers Visit website Investor relations